Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022)
Phibro Animal Health's (PAHC) quarterly Non-Current Deferred Tax Liability came in at $8.8 million in Q1 2022, down 28.45% year-on-year from $12.4 million in Q1 2021, and up 9.72% quarter-over-quarter from $8.1 million in Q4 2021.
Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022) Analysis & Trends
Phibro Animal Health's Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $8.8 million for Q1 2022.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 28.45% year-over-year to $8.8 million in Q1 2022; TTM through Mar 2022 was $8.8 million, a 28.45% decrease from a year earlier, with the FY2021 full-year figure at $6.6 million, up 451.54% from the prior year.
- Non-Current Deferred Tax Liability climbed to $8.8 million in Q1 2022 per PAHC's latest filing, from $8.1 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $12.4 million in Q1 2021 and bottomed at $1.2 million in Q2 2020.
- The 4-year median for Non-Current Deferred Tax Liability is $8.8 million (2022), against an average of $7.8 million.
- Across the five-year window, Non-Current Deferred Tax Liability slumped 36.07% in 2020 and surged 451.54% in 2021, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $9.5 million in 2019, then climbed by 26.6% to $12.1 million in 2020, then slumped by 33.09% to $8.1 million in 2021, then gained by 9.72% to $8.8 million in 2022.
- Per Business Quant, the three latest PAHC Non-Current Deferred Tax Liability figures stand at $8.8 million (Q1 2022), $8.1 million (Q4 2021), and $7.3 million (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 8.85 Mn |
| Mar 31, 2022 | 8.85 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Mar 31, 2021 | 12.37 Mn |
| Mar 31, 2021 | 12.37 Mn |
| Dec 31, 2020 | 12.05 Mn |
| Dec 31, 2020 | 12.05 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Mar 31, 2020 | 9.29 Mn |
| Mar 31, 2020 | 9.29 Mn |
| Dec 31, 2019 | 9.52 Mn |
| Dec 31, 2019 | 9.52 Mn |
| Sep 30, 2019 | 9.02 Mn |
| Sep 30, 2019 | 9.02 Mn |